p53/TP53“The guardian of the genome” -a transcription factor –
its loss leads to genomic instability and increased mutagenesis.
Restrainsuncontrolledcellgrowth–blockcellcycleandinduce
apoptosis.
Sensemultiplecellularstresses(genotoxicstresse.g.,UV,X-ray,carcinogens,
andcytotoxicdrugs)oroncogenicstresses(hyperproliferativesignalsfrom
oncogenes).
Inresponsetostress,thep53proteinisstabilizedandactivated-
induceasetofgenesinvolvedincellcyclearrest,DNArepair,or
apoptosis.
p53isinactivatedinmosthumancancers(50%oftumors)asaresultofmutations
intheTP53gene,orthroughbindingtoviralproteins.
Tumorsuppressoractivityofp53isduetoitsabilitytoinduceapoptosis
TumorSuppressor genes, Dr.DhanyaKC, St.Mary'sCollege, Thrissur
REGRESSING TUMORS BY ACTIVATING TUMOR SUPPRESSOR GENES
–A THERAPEUTIC TARGET
Preclinical studies both in vitro and in vivo have shown that restoring
p53 function can induce apoptosis in cancer cells.
P53 gene therapy for lung cancer, hepatocellular carcinoma using
viral delivery system.
However, resistance develops in many patients, suggesting that
combination of such gene-targeted therapies may be required.
TumorSuppressor genes, Dr.DhanyaKC, St.Mary'sCollege, Thrissur